share_log

S-1: General form for registration of securities under the Securities Act of 1933

S-1: General form for registration of securities under the Securities Act of 1933

S-1:證券上市註冊聲明
美股sec公告 ·  04/16 17:26
Moomoo AI 已提取核心訊息
Applied UV, Inc. (Applied UV), a Nevada-based company specializing in disinfection technology, has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) on April 16, 2024, for a Form S-1 Registration Statement. The company, which operates through its subsidiaries SteriLumen, Inc. and Munn Works, LLC, is known for its air and surface disinfection products that serve various markets including healthcare, hospitality, and food preservation. The registration statement pertains to the proposed sale of 518,065 shares of common stock, issuable upon the exercise of warrants from a private placement conducted on April 1, 2024. The selling stockholders may sell these shares through public or private transactions, and the company will not receive any proceeds from the sale of shares by the...Show More
Applied UV, Inc. (Applied UV), a Nevada-based company specializing in disinfection technology, has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) on April 16, 2024, for a Form S-1 Registration Statement. The company, which operates through its subsidiaries SteriLumen, Inc. and Munn Works, LLC, is known for its air and surface disinfection products that serve various markets including healthcare, hospitality, and food preservation. The registration statement pertains to the proposed sale of 518,065 shares of common stock, issuable upon the exercise of warrants from a private placement conducted on April 1, 2024. The selling stockholders may sell these shares through public or private transactions, and the company will not receive any proceeds from the sale of shares by the selling stockholders. However, if the warrants are exercised for cash, Applied UV may receive approximately $8.3 million, intended for general corporate purposes, including working capital. The common stock is listed on The Nasdaq Capital Market under the symbol 'AUVI'. The company's stock price has been subject to fluctuations, and investing in the common stock involves a high degree of risk. The registration statement includes detailed information about the company's business, financial condition, and the risks associated with the offering.
總部位於內華達州的專門從事消毒技術的公司應用紫外線公司(Applied UV)已於2024年4月16日向美國證券交易委員會(SEC)提交了S-1表格註冊聲明的註冊聲明。該公司通過其子公司SteriluMen, Inc.和Munn Works, LLC運營,以其空氣和表面消毒產品而聞名,這些產品服務於醫療保健、酒店和食品保鮮等各個市場。註冊聲明涉及518,065股普通股的擬議出售,這些普通股可在行使2024年4月1日進行的私募認股權證後發行。出售股東可以通過公開或私人交易出售這些股票,並且公司不會從出售股票的股東出售股票中獲得任何收益。但是,如果認股權證以現金行使,則Applied UV可能獲得約830萬美元,用於一般公司用途,包括營運資金。普通股在納斯達克資本市場上市,股票代碼爲 “AUVI”。該公司的股價一直受到波動,投資普通股涉及很高的風險。註冊聲明包括有關公司業務、財務狀況以及與本次發行相關的風險的詳細信息。
總部位於內華達州的專門從事消毒技術的公司應用紫外線公司(Applied UV)已於2024年4月16日向美國證券交易委員會(SEC)提交了S-1表格註冊聲明的註冊聲明。該公司通過其子公司SteriluMen, Inc.和Munn Works, LLC運營,以其空氣和表面消毒產品而聞名,這些產品服務於醫療保健、酒店和食品保鮮等各個市場。註冊聲明涉及518,065股普通股的擬議出售,這些普通股可在行使2024年4月1日進行的私募認股權證後發行。出售股東可以通過公開或私人交易出售這些股票,並且公司不會從出售股票的股東出售股票中獲得任何收益。但是,如果認股權證以現金行使,則Applied UV可能獲得約830萬美元,用於一般公司用途,包括營運資金。普通股在納斯達克資本市場上市,股票代碼爲 “AUVI”。該公司的股價一直受到波動,投資普通股涉及很高的風險。註冊聲明包括有關公司業務、財務狀況以及與本次發行相關的風險的詳細信息。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息